AbbVie (ABBV) Cash from Operations Growth (5y) (2017 - 2026)

AbbVie (ABBV) Cash from Operations Growth (5y) (2017 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Novartis Ag 108.28 Bn 107.60 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -4.72%
Dec 31, 2025 1.46%
Sep 30, 2025 3.80%
Jun 30, 2025 10.78%
Mar 31, 2025 -15.59%
Dec 31, 2024 16.57%
Sep 30, 2024 3.64%
Jun 30, 2024 -1.72%
Mar 31, 2024 6.01%
Dec 31, 2023 6.98%
Sep 30, 2023 10.86%
Jun 30, 2023 17.13%
Mar 31, 2023 9.65%
Dec 31, 2022 23.51%
Sep 30, 2022 252.34%
Jun 30, 2022 228.92%
Mar 31, 2022 18.48%
Dec 31, 2021 26.92%
Sep 30, 2021 40.41%
Jun 30, 2021 20.58%